NASDAQ: ACST - Acasti Pharma Inc.

Yield per half year: +0.597%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Acasti Pharma Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Acasti Pharma Inc.

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2011-05-06
ISIN CA00430K8730
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.acastipharma.com
Цена ао 3.37
Change price per day: 0% (3.37)
Change price per week: 0% (3.37)
Change price per month: 0% (3.37)
Change price per 3 month: 0% (3.37)
Change price per half year: +0.597% (3.35)
Change price per year: +0.2976% (3.36)
Change price per 3 year: +200.89% (1.12)
Change price per 5 year: +1 219.5% (0.2554)
Change price per year to date: 0% (3.37)
All parameters

Underestimation

Title Value Grade
P/S 26141.39 1
P/BV 0.5263 10
P/E 0 0
EV/EBITDA -0.8397 0
Total: 4

Efficiency

Title Value Grade
ROA, % -19.5 0
ROE, % -22.95 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0318 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % -97.69 0
Yield Ebitda, % -27.09 0
Yield EPS, % -87.03 0
Total: 0
More

Institutions Volume Share, %
Bank of America Corporation 494698 5.26
Adar1 Capital Management, LLC 34532 0.37
Royal Bank of Canada 31584 0.34
UBS Group AG 5602 0.06
National Bank of Canada/FI 2901 0.03
Morgan Stanley 1882 0.02
Advisory Services Network, LLC 41 0
ICA Group Wealth Management, LLC 9 0
Nbc Securities, Inc. 2 0



Head Job title Payment Year of birth
Mr. Prashant Kohli CEO & Director 358.41k 1972 (53 years)
Dr. R. Loch MacDonald M.D., Ph.D. Member of Scientific Advisory Board & Chief Medical Officer N/A 1962 (63 years)
Mr. Amresh Kumar Ph.D. VP of Program Management N/A 1980 (45 years)
Mr. Robert J. DelAversano CPA VP of Finance and Principal Financial & Accounting Officer N/A 1972 (53 years)
Ms. Carrie D'Andrea VP of Clinical Operations 1972 (53 years)

Address: Canada, Laval. QC HE B, 3009 boulevard de la Concorde East - open in Google maps, open in Yandex maps
Website: https://www.acastipharma.com